📰 Rom News
Page 363 - Rom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.
June 4, 2023
Drive Shack Inc. today announced it had amended its Tax Benefits Preservation Plan in connection with the company’s voluntary delisting from the New York Stock Exchange and deregistration of... | June 4, 2023
June 4, 2023
Newest edition of National Footprint and Biocapacity Accounts reports trends of the world and over 180 countries up to 2022. GENEVA, June 4, 2023 /PRNewswire/ -- August 2nd marks this year's
June 4, 2023
Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the... | June 4, 2023
June 4, 2023
- Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily pre-treated GIST patients, including 100% DCR and 17% overall response rate (ORR) in efficacy evaluable
June 4, 2023
Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the... | June 4, 2023
June 4, 2023
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndromeA high proportion of patients had tumor biomarker reduction (77%) with 32% having complete clearanceRobust
June 4, 2023
- Met Primary Endpoint with 63.4% Median Reduction in LDL-C (p - 87.1% of Patients Treated with Combination of Obicetrapib and Ezetimibe Met Guideline-Recommended LDL-C Goal of - New Data Demonstrate
June 4, 2023
Actor Parineeti Chopra on Saturday dropped a sweet birthday wish for her father Pawan Chopra.
June 4, 2023
Updated data from ongoing IGNYTE anti-PD1 failed melanoma cohort shows RP1 combined with nivolumab continues to demonstrate deep and durable responses with a well-tolerated safety profile; no progression
June 4, 2023
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the presentation of biomarker findings from a Phase II study of alisertib plus paclitaxel versus paclitaxel alone in metastatic... | June 4, 2023